30. Meyers BF, Patterson GA. Lung transplantation. In Pearson GF, Cooper JD, eds. Thoracic Surgery. Philadelphia, Pennsylvania: Churchill Livingstone, 2002.

31. Date H, Triantafillou AN, Trulock EP et al. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996 May; 111(5):913-919.

32. Meyers BF, Sundt TM, Henry S et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000; 120:20-30.

33. Herridge MS, de Hoyos A, Chaparro C et al. Pleural complications in lung transplant recipients. J Thorac Cardiovasc Surg 1995; 110:22-26.

34. Madill J, Maurer J, de Hoyos A. Comparison of pre-operative and post-operative nutritional states of lung transplant recipients. Transplantation1993; 56:347-350.

35. Snell G, de Hoyos A, Winton T et al. Pseudomonas cepacia infections in cystic fibrosis patients after lung transplantation. Chest 1993; 103:466-471.

36. Fishman JA, Rubin RH. Infections in organ-transplant recipients. N Engl J Med 1998; 338:1741-1751.

37. Wreghitt T. Cytomegalovirus infections in heart and heart-lung transplant recipients. J Antimicrob Chemother 1898; 23(Suppl E):49-60.

38. Zamora MR. Controversies in lung transplantation: Management of cytomegalovirus infection. J Heart Lung transplant 2002; 21:841-849.

39. Maurer JR, Snell G, de Hoyos A et al. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc 1993; 25:1434-1435.

40. Limaye AP, Corey L, Koelle DM et al. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000; 356:645-649.

41. Reichenspurner H, Kur F, Treede H. Optimization of the immunosuppressive protocol after lung transplantation. Transplantation 1999; 68:67-71.

42. Keenan RJ, Konishi H, Kawai A et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995; 60:580-584.

43. Kur F, Reichenspurner H, Meiser BM et al. Tacrolimus (FK-506) as primary immunosuppressant after lung transplantation. Thorac Cardiovasc Surg 1999:47:174-178.

44. de Hoyos A. Maurer J. Complications after lung transplantation. Sem Thorac Cardiovasc Surg 1992; 4:132-146.

45. Date H, Trulock EP, Arcidi JM et al. Improved airway healing after lung transplantation: AN analysis of 348 bronchial anastomoses. J Thorac Cardiovasc Surg 1995; 110:1424-1435.

46. Cooper JD, Pearson FG, Patterson GA et al. Use of silicone stents in the management of airway problems. Ann Thorac Surg 1989; 47:371-382.

47. Novick RJ, Stitt L. Pulmonary retransplantation. Sem Thorac Cardiovasc Surg 1998; 10:227-231.

48. Cooper JD, Billingham M, Eagan T. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allogrfafts. J Heart Lung Transplant 1993; 12:713-720.

49. Trulock EP. Management of lung transplant rejection. Chest 1993 May; 103(5):1566-1576.

50. Trulock EP, Ettinger NA, Brunt EM et al. The role of transbronchial biopsy in the treatment of lung transplant recipients. An analysis of 2000 consecutive procedures. Chest 1992; 102:1049-1054.

51. de Hoyos A, Chamberlain D, Shvarztman R et al. Assessment of a standardized pathological grading system of acute rejection in isolated lung transplantation. Chest 1993; 103:1813:1818.

0 0

Post a comment